Arcellx Inc (ACLX)
87.22
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
87.15
-0.07
(-0.08%)
After-Hours: 20:00
Arcellx Enterprise Value: 4.142B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 4.142B |
| November 20, 2024 | 4.142B |
| November 19, 2024 | 4.162B |
| November 18, 2024 | 4.196B |
| November 15, 2024 | 4.175B |
| November 14, 2024 | 4.567B |
| November 13, 2024 | 4.841B |
| November 12, 2024 | 4.859B |
| November 11, 2024 | 5.186B |
| November 08, 2024 | 4.999B |
| November 07, 2024 | 4.788B |
| November 06, 2024 | 4.454B |
| November 05, 2024 | 4.137B |
| November 04, 2024 | 4.100B |
| November 01, 2024 | 4.085B |
| October 31, 2024 | 3.976B |
| October 30, 2024 | 4.113B |
| October 29, 2024 | 4.137B |
| October 28, 2024 | 4.015B |
| October 25, 2024 | 3.978B |
| October 24, 2024 | 4.095B |
| October 23, 2024 | 4.188B |
| October 22, 2024 | 4.310B |
| October 21, 2024 | 4.300B |
| October 18, 2024 | 4.656B |
| Date | Value |
|---|---|
| October 17, 2024 | 4.570B |
| October 16, 2024 | 4.447B |
| October 15, 2024 | 4.280B |
| October 14, 2024 | 4.113B |
| October 11, 2024 | 4.080B |
| October 10, 2024 | 3.902B |
| October 09, 2024 | 3.904B |
| October 08, 2024 | 3.791B |
| October 07, 2024 | 3.533B |
| October 04, 2024 | 3.650B |
| October 03, 2024 | 3.540B |
| October 02, 2024 | 3.542B |
| October 01, 2024 | 3.823B |
| September 30, 2024 | 3.935B |
| September 27, 2024 | 3.932B |
| September 26, 2024 | 4.006B |
| September 25, 2024 | 4.031B |
| September 24, 2024 | 4.022B |
| September 23, 2024 | 4.105B |
| September 20, 2024 | 4.139B |
| September 19, 2024 | 4.076B |
| September 18, 2024 | 3.813B |
| September 17, 2024 | 3.676B |
| September 16, 2024 | 3.623B |
| September 13, 2024 | 3.617B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
46.73M
Minimum
May 18 2022
5.186B
Maximum
Nov 11 2024
1.585B
Average
1.203B
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 143.48B |
| AbbVie Inc | 367.30B |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -25.87M |
| Revenue (Quarterly) | 26.03M |
| Total Expenses (Quarterly) | 59.65M |
| EPS Diluted (Quarterly) | -0.48 |
| Profit Margin (Quarterly) | -99.37% |
| Earnings Yield | -0.81% |
| Normalized Earnings Yield | -0.814 |